The in situ clusters in all of these cases exhibited no statistically significant differences in E-cadherin membrane or Ki-67 nuclear proliferation immunoreactivities compared to those exhibited by the tumor emboli within the lymphovascular channels (p = 0.5; p = 0.5) (Figure 7A; Figure 7B; Figure 7C; Figure 7D; Figure 7E) (Table 2). This evidence concerns the gene CDH1 and neoplasm.